Structural integrity of balloon-expandable stents after transcatheter aortic valve replacement: assessment by multidetector computed tomography

JACC Cardiovasc Interv. 2012 May;5(5):525-532. doi: 10.1016/j.jcin.2012.03.007.

Abstract

Objectives: This study sought to evaluate the structural integrity of balloon-expandable stents used in transcatheter aortic valve replacement.

Background: Underexpansion, deformation, or fracture of stent frames may affect transcatheter heart valve (THV) function and durability.

Methods: Patients >1 year after transcatheter aortic valve replacement underwent multidetector computed tomography. Geometry of the stent frame was assessed for circularity; eccentricity; minimum and maximum external diameter; and expansion at the inflow, mid-stent, and outflow levels, as well as for stent fracture. THV noncircularity was defined as stent eccentricity >10% (1 - minimum diameter/maximum diameter) and THV underexpansion when expansion <90% (multidetector computed tomography derived external valve area/nominal external valve area). Echocardiography was performed after implantation and annually.

Results: Fifty patients underwent multidetector computed tomography at an average of 2.5 ± 0.9 years after transcatheter aortic valve replacement (35 Sapien, 8 Sapien XT, and 7 Cribier-Edwards valves [all Edwards Lifesciences, Irvine, California). The mean external diameter for the 23- and 26-mm valves was 23.3 ± 0.9 mm and 25.9 ± 0.9 mm, respectively. Circularity was present in 96% (48 of 50) and median eccentricity was 2.0% (interquartile range: 1.2% to 3.0%). Mean THV expansion was 104.1 ± 7.4%, which increased from stent inflow to outflow (100.8 ± 7.6% vs. 108.1 ± 6.9%, p < 0.001). Stent fracture was not observed. Underexpanded valves (8% [4 of 50]) and noncircular valves (4% [2 of 50]) demonstrated stable hemodynamic function on annual echocardiography.

Conclusions: Balloon-expandable aortic valves have excellent rates of circularity with low eccentricity and maintain full expansion without stent fracture at an average 2.5 years after implantation.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Aortic Valve Stenosis / therapy*
  • British Columbia
  • Cardiac Catheterization / adverse effects
  • Cardiac Catheterization / instrumentation*
  • Echocardiography
  • Female
  • Heart Valve Prosthesis Implantation / adverse effects
  • Heart Valve Prosthesis Implantation / instrumentation*
  • Heart Valve Prosthesis*
  • Humans
  • Male
  • Multidetector Computed Tomography*
  • Predictive Value of Tests
  • Prosthesis Design
  • Prosthesis Failure*
  • Stents*
  • Time Factors
  • Treatment Outcome